SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-05-178117
Filing Date
2005-08-31
Accepted
2005-08-31 15:12:42
Documents
6
Period of Report
2005-08-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K FOR SYNBIOTICS CORPORATION d8k.htm 8-K 24591
2 FIFTH AMENDMENT TO CREDIT AGREEMENT AND LOAN DOCUMENTS dex4410.htm EX-4.4.10 31185
3 PROMISSORY NOTE FROM THE REGISTRANT TO JERRY L. RUYAN dex4411.htm EX-4.4.11 13405
4 PROMISSORY NOTE FROM THE REGISTRANT TO BARNES-JEWISH HOSPITAL dex47.htm EX-4.7 16329
5 PROMISSORY NOTE FROM THE REGISTRANT TO REMINGTON CAPITAL dex48.htm EX-4.8 12670
6 FRAMEWORK AGREEMENT dex10691.htm EX-10.69.1 13606
  Complete submission text file 0001193125-05-178117.txt   113486
Mailing Address 11011 VIA FRONTERA SAN DIEGO CA 92127
Business Address 11011 VIA FRONTERA SAN DIEGO CA 92127 8584513771
SYNBIOTICS CORP (Filer) CIK: 0000719483 (see all company filings)

IRS No.: 953737816 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-11303 | Film No.: 051061677
SIC: 2835 In Vitro & In Vivo Diagnostic Substances